FRANKFURT: The CEO of pharmaceuticals giant Roche, opens new tab said authorities should block the takeover of contract drug ...
Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...
Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...
GLP-1 receptor agonists and SGLT2 inhibitors were both initially approved for type 2 diabetes. But over the last several ...
With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...
GLP-1 drugs such as Novo Nordisk's Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...
As more women speak openly about menopause and the changes it brings, some doctors say GLP-1 medications like Ozempic and ...
Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
Eat well: Strive to have an overall healthy diet that includes whole foods, lots of fruits and vegetables, lean protein, nuts ...